Comprehensive medication management may lower costs and improve lives.
"The real problem to be solved is “Why do patients struggle to buy their prescriptions?” writes Frisch.
How can we protect the health of the millions of people who protect our own?
Pharmacists must continue to minimize the convenience gap between physician and pharmacy.
Pharmacists must continue to minimize the convenience gap between physician and pharmacy.
Prescribing more hormonal methods is an important expansion of existing services and offerings.
Cariprazine demonstrated greater improvement on the MADRS.
"Community pharmacies have reasons to be optimistic..." writes Jhaveri.
Indicated as part of a three-drug oral combination.
Simon Murray, MD, recently spent the day with Chris Castagna, RPh, an independent pharmacist.
The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Off-label drug combinations are increasingly being used in cancer treatments, but there is the potential for overlapping or additive toxicities, explained a speaker at the 2023 HOPA Annual Conference.
Although COVID-19 remains a real threat, it seems we are now progressing toward a return to normalcy thanks to the widespread availability of vaccines and tireless efforts of our health care workers.
Leverage internal partnerships and demonstrate the value of data
What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.
Mebella is another weapon in the global fight to eradicate these diseases.
Data from one study showed younger women more likely to use sunscreen than older adults.
The critical role of distributors amid natural disasters, and strategies to protect and maintain the pharma supply chain
What are some of the factors affecting whether a brand-name drug has generic competition?
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
In many industries, tipping is the norm. Pharmacists would just like to receive payment for services rendered.
Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.
Following the Federal Trade Commission’s interim report on PBMs, legislators are galvanized to make change happen.
It’s never too far into flu season to educate patients.
Most pharmacists are moderately to not-at-all comfortable answering patient questions about cannabis. That needs to change.
Pharmacies, just as expected, have showed up in meaningful ways to support their communities.
The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.